- Home
- Life Sciences
- Biotechnology
- Biological Therapy
- Biological Therapy Analysis & Statistics, May 2013
Talk to Robyn
00 1 718 213 49 04
Search inside this page
Top countries
Publication dates
Publishers
- Global Data (119)
- Bioseeker (17)
- Global Markets Direct (80)
- France Innovation Scientifique et Transfert (4)
- MarketLine (11)
-
- Kuick Research (1)
- La Merie Publishing (8)
- Datamonitor (18)
- Axis Research Mind (15)
- Life Science Analytics (LSA) (13)
- GBI Research (11)
- Frost & Sullivan (10)
- Global Industry Analyst (10)
- Espicom Business Intelligence (6)
- BCC Research (4)
- Visiongain (4)
- CHI Insight Pharma Reports (3)
- Industry Experts (3)
- Infiniti Research Limited (3)
- RNCOS (3)
- TriMark Publications (3)
- Aruvian's R'search (2)
- BioInformatics (2)
- Currentpartnering (2)
- MarketsandMarkets (2)
- Pharmavision (2)
- SCRIP Insights (2)
- Barnes Reports (1)
- BioPharm Reports (1)
- Daedal Research (1)
- Ibisworld (1)
- PMR Ltd. (1)
- Transparency Market Research (1)
- Venture Planning Group (1)
All regions
data types
Free Market Research Guides to Download
Biological Therapy Analysis & Statistics, May 2013
You might be interested in: stem cell, cell therapy, cytokine, more »
» Purchase Premium Reports
1-30 of about 400 reports
Analytical Tool - Cancer Immunotherapy
- $ 8 175
- Industry report
- April 2013
- by Bioseeker
"Analytical Tool- Cancer Immunotherapy" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It ...
- Industries : Biological Therapy
iPS cell Generation patent landscape - 2013/03
- $ 6 860
- Industry report
- May 2013
- by France Innovation Scientifique et Transfert
Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged ...
- Industries : Biological Therapy
- Countries : United States, South Korea, China
Analytical Tool - Cancer Therapeutic Antibodies
- $ 5 924
- Industry report
- April 2013
- by Bioseeker
"Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer. ...
- Industries : Biological Therapy
iPS cell Differentiation patent landscape - 2013/03
- $ 4 060
- Industry report
- May 2013
- by France Innovation Scientifique et Transfert
Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged ...
- Industries : Biological Therapy
- Countries : United States, South Korea, China
Immunotherapy in Oncology Drug Pipeline Update 2013
- $ 3 675
- Industry report
- April 2013
- by Bioseeker
Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...
- Industries : Biological Therapy
B-Cell Leukemia - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
B-Cell Leukemia - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'B-Cell Leukemia - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...
- Industries : Biological Therapy
- Countries : World
World Biological Therapy: T-Cell Leukemia - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides information on the therapeutic development for T-Cell Leukemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Biological Therapy
- Countries : Japan, World
World Biological Therapy: Natural Killer Cell Lymphomas - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides information on the therapeutic development for Natural Killer Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...
- Industries : Biological Therapy
- Countries : United States, World
Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2013', provides an overview of the indication's ...
- Industries : Biological Therapy
- Countries : World, United States
Cancer Stem Cells Drug Pipeline Update 2013
- $ 2 249
- Industry report
- April 2013
- by Bioseeker
Treatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and cancer drugs which ...
- Industries : Biological Therapy
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013
- $ 2 249
- Industry report
- April 2013
- by Bioseeker
The androgen receptor signaling pathway activates the SMAD signaling module. There are today 313 companies plus partners developing 395 Androgen Receptor drugs in 1261 developmental projects in cancer. ...
- Industries : Biological Therapy
B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013
- $ 2 249
- Industry report
- April 2013
- by Bioseeker
Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several non-recepto ...
- Industries : Biological Therapy
EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2013
- $ 2 249
- Industry report
- April 2013
- by Bioseeker
The EGFR1 signaling pathway activates the Ras/Raf/MAPK signaling modules. There are today 351 companies plus partners developing 554 EGFR1 pathway targeting drugs in 1998 developmental projects in cancer. ...
- Industries : Biological Therapy
Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2013
- $ 2 249
- Industry report
- April 2013
- by Bioseeker
Cytokines are soluble extracellular proteins or glycoproteins that are crucial intercellular regulators and mobilizers of cells engaged in innate as well as adaptive inflammatory host defenses, cell growth, ...
- Industries : Biological Therapy
Gene Therapy in Oncology Drug Pipeline Update 2013
- $ 2 249
- Industry report
- April 2013
- by Bioseeker
There are today 120 companies plus partners developing 109 gene therapy drugs in 257 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs ...
- Industries : Biological Therapy
Notch Signaling Pathway in Oncology Drug Pipeline Update 2013
- $ 2 249
- Industry report
- April 2013
- by Bioseeker
Aberrant Notch signaling has been linked to a number of malignancies including leukemias, lymphomas and carcinomas of the breast, skin, lung, cervix and kidneys. There are today 159 companies plus partners ...
- Industries : Biological Therapy
T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013
- $ 2 249
- Industry report
- April 2013
- by Bioseeker
Stimulation of the T cell receptor leads to the activation of NFkB and NFAT signaling modules which play a key role in T cell receptor signaling. There are today 219 companies plus partners developing ...
- Industries : Biological Therapy
TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013
- $ 2 249
- Industry report
- April 2013
- by Bioseeker
The TGF-beta receptor signaling pathway activates the MAPK/SMAD signaling modules. There are today 257 companies plus partners developing 344 TGF-beta receptor pathway targeting drugs in 1128 developmental ...
- Industries : Biological Therapy
TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2013
- $ 2 249
- Industry report
- April 2013
- by Bioseeker
The TNF-alfa signaling pathway stimulates the MAPK signaling module and activates NFkB. There are today 238 companies plus partners developing 296 TNF-alpha pathway targeting drugs in 1016 developmental ...
- Industries : Biological Therapy
Wnt Signaling Pathway in Oncology Drug Pipeline Update 2013
- $ 1 499
- Industry report
- April 2013
- by Bioseeker
Abnormalities in the Wnt signaling pathway are associated with a large variety of human malignancies including tumors of breast, colon, pancreas, liver and bone. There are today 103 companies plus partners ...
- Industries : Biological Therapy
TiGenix NV (TIG) - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- May 2013
- by Global Data
Summary TiGenix NV (TiGenix) is a biomedical cell therapy company. The company specializes in the development of innovative local treatments for damaged and diseased tissues. It mainly focuses on the therapeutic ...
- Industries : Biological Therapy
- Countries : Spain
Cytokine PharmaSciences, Inc. - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- May 2013
- by Global Data
Summary Cytokine PharmaSciences, Inc. (CPSI) is a biopharmaceutical company. The company develops drug delivery products in the area of women's health; and small molecule therapeutics in the areas of autoimmune ...
- Industries : Biological Therapy
- Countries : United States
Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- May 2013
- by Global Data
Summary Cytograft Tissue Engineering, Inc. (CTE) is a genetic engineering company. The company develops cell-based solutions for the treatment of cardiovascular diseases. It has developed a regenerative ...
- Industries : Biological Therapy
- Countries : United States
Bioheart, Inc. (BHRT) - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- April 2013
- by Global Data
Summary Bioheart, Inc. (Bioheart) is a biotechnology company. It focus on the treatment of cardiovascular related diseases. It discovers, develops and commercializes autologous cell therapies to treat ...
- Industries : Biological Therapy
- Countries : United States
Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2013
- $ 749
- Industry report
- April 2013
- by Bioseeker
Aberrant activation of the Hedgehog pathway has been associated with a number of human malignancies including carcinoma of lung, esophagus, pancreas and prostate. There are today 55 companies plus partners ...
- Industries : Biological Therapy
ID Signaling Pathway in Oncology Drug Pipeline Update 2013
- $ 749
- Industry report
- April 2013
- by Bioseeker
Inhibitor of DNA binding (ID) proteins are members of the helix-loop-helix (HLH) family of proteins which lack a DNA binding domain themselves but bind to other family members inhibiting their DNA binding ...
- Industries : Biological Therapy
India Stem Cell Banking Market Analysis
- $ 500
- Industry report
- April 2013
- by Kuick Research
Stem Cell Banking has emerged as new opportunity of healthcare services provider in Indian market. The market is still in nascent stage of development and valued at more than INR 400 Crore (US$ 70 Million) ...
- Industries : Biological Therapy
- Countries : India
Competitor Analysis: G-CSF and GM-CSF
- $ 516
- Industry report
- April 2013
- by La Merie Publishing
Product description The present Competitive Intelligence Report about G-CSF and GM-CSF product portfolios and R&D pipelines provides a competitor evaluation in the field of G-CSF & GM-CSF branded products ...
- Industries : Biological Therapy
- Countries : Taiwan, South Korea, India, China
BioHeart, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Biological Therapy
International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Biological Therapy
» Download Public Reports
About 800 reports
StemCells Inc. - Company Report for Year 2013
- Company report
- March 2013
- 30 pages
... Biotechnology company. Gfap and nestin are proteins that are co-expressed by certain key cells found in the human central nervous system. Each patent claims a cell culture of undifferentiated gfap+ nestin+ cells ...
Cell Therapy Market Analysis In The United Kingdom
February 2013» Read our Company Profiles
36 CompaniesGlaxoSmithKline P.L.C.
United StatesBioheart Inc.
United StatesCelgene Corp.
United StatesStemCells Inc.
United StatesGeron Corp.
United StatesReportlinker.com © Copyright 2013. All rights reserved.
